V
ViroVet develops antiviral drugs for treating respiratory diseases in cattle and swine and innovative PLLAV vaccines for viral infections. Their vaccine technology allows for inexpensive, tailor-made modified live virus vaccines that eliminate the cold chain requirement. The company's fast-acting antivirals reduce antibiotic use associated with endemic and epizootic livestock diseases.
Updated 18 months ago
Funding
$20.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- ViroVet develops antiviral drugs for treating respiratory diseases in cattle and swine and innovative PLLAV vaccines for viral infections. Their vaccine technology allows for inexpensive, tailor-made modified live virus vaccines that eliminate the cold chain requirement. The company's fast-acting antivirals reduce antibiotic use associated with endemic and epizootic livestock diseases.